Apogee Therapeutics, Inc. - Common Stock (APGE)

Historical Holders from Q3 2023 to Q3 2025

Symbol
APGE on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
46.1M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
59.6M
Holdings value
$2.37B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
172
Number of buys
85
Number of sells
-89
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Apogee Therapeutics, Inc. - Common Stock (APGE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% $266M 6.91M FMR LLC 30 Jun 2025
Fairmount Funds Management LLC 9.99% $230M 5.78M Peter Evan Harwin 10 Oct 2025
WELLINGTON MANAGEMENT GROUP LLP 10.6% +28.8% $188M $41.6M 4.89M +28.4% Wellington Management Group LLP 31 Jul 2025
RTW INVESTMENTS, LP 6% $102M 2.71M RTW Investments, LP 31 Dec 2024
BlackRock, Inc. 5.5% $109M 2.52M BlackRock, Inc. 30 Jun 2025
DRIEHAUS CAPITAL MANAGEMENT LLC 4.68% $85.8M 2.16M DRIEHAUS CAPITAL MANAGEMENT LLC 30 Sep 2025

Institutional Holders of Apogee Therapeutics, Inc. - Common Stock (APGE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 59.6M $2.37B +$56.5M $39.73 172
2025 Q2 57.8M $2.51B -$147M $43.43 180
2025 Q1 61.5M $2.3B +$131M $37.36 165
2024 Q4 57.9M $2.62B +$63.3M $45.30 156
2024 Q3 56.1M $3.29B +$134M $58.74 137
2024 Q2 54.2M $2.13B -$9.8M $39.35 137
2024 Q1 52.9M $3.52B +$778M $66.45 137
2023 Q4 41.8M $1.16B +$48.1M $27.94 85
2023 Q3 40.1M $849M +$849M $21.30 73